PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Philis-Tsimikas, Athena
TI  - Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Uncontrolled Patients with Type 2 Diabetes on Oral Agents
DP  - 2012 Dec 01
TA  - MD Conference Express
PG  - 20--20
VI  - 12
IP  - 16
4099  - http://mdc.sagepub.com/content/12/16/20.short
4100  - http://mdc.sagepub.com/content/12/16/20.full
AB  - Insulin degludec is superior to sitagliptin in improving glycemic control in patients with type 2 diabetes mellitus uncontrolled by oral antidiabetic drugs (OADs). This article discusses the results of the comparison of NN1250 with Sitagliptin in Subjects with Type 2 Diabetes Never Treated with Insulin [BEGIN®: EARLY; NCT01046110] trial that compared basal insulin with a dipeptidyl peptidase-4 inhibitor as an add-on to OADs.